Research indicates that FSCN1 may serve as a novel biomarker for the progression of HCC and an important indicator of poor prognosis in HCC patients8,9, and FSCN1 plays a crucial role in the formation and malignant transformation process of HCC10. This evidence concerns the gene FSCN1 and hepatocellular carcinoma.